Fig. 6From: m6A-modified circARHGAP12 promotes the aerobic glycolysis of doxorubicin-resistance osteosarcoma by targeting c-Mycm6A-modified circARHGAP12 promoted the aerobic glycolysis of doxorubicin-resistance osteosarcoma through m6A/c-Myc mannerBack to article page